Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.S. Codex Likely To Advocate Voluntary Quantitative Food Labeling

This article was originally published in The Tan Sheet

Executive Summary

Inclusion of quantitative ingredient information on prepackaged food labels should remain voluntary, food industry stakeholders tell Christine Lewis, PhD, the U.S. voting delegate to the Codex Committee on Food Labeling.

You may also be interested in...



Supplement Trade Interests Need U.S. Voice At Codex Mtgs. -Rep. Pallone

A government trade expert familiar with dietary supplement issues should work with the U.S. Codex delegation to help ensure the principles of the Dietary Supplement Health & Education Act are upheld in Codex initiatives, House Government Reform Committee members suggested at a hearing March 20.

Supplement Trade Interests Need U.S. Voice At Codex Mtgs. -Rep. Pallone

A government trade expert familiar with dietary supplement issues should work with the U.S. Codex delegation to help ensure the principles of the Dietary Supplement Health & Education Act are upheld in Codex initiatives, House Government Reform Committee members suggested at a hearing March 20.

Supplement Trade Interests Need U.S. Voice At Codex Mtgs. -Rep. Pallone

A government trade expert familiar with dietary supplement issues should work with the U.S. Codex delegation to help ensure the principles of the Dietary Supplement Health & Education Act are upheld in Codex initiatives, House Government Reform Committee members suggested at a hearing March 20.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS092356

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel